The cagrilintide + retatrutide stack is a two-compound research protocol that pairs two of the most powerful weight-loss peptides in late-stage development
One study found that the addition of SM, EO, STS, or POL to citrated plasma did not cause clotting nor shorten either the prothrombin time (PT) or the partial thromboplastin time (PTT)
These doses were calibrated against 80% bioavailability from subcutaneous injection
We suspect that metabolic/bioenergetic reprograming, observed in this study, could also mediate short-term maintenance of -cell function upon withdrawal of GLP-1 analogues, as documented in humans and rodents by others 21, 33
DIRECTIONS: Take 4 ml (0.81 tsp) daily, or as directed by your physician
Stability can be extended if frozen with a suitable cryoprotectant